Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Newron Pharmaceuticals SpA

+ Add to Watchlist

NWRN:SW

28.85 CHF 0.35 1.20%

As of 11:33:58 ET on 05/29/2015.

Company Profile for Newron Pharmaceuticals SpA (NWRN)

Newron Pharmaceuticals SpA is a research and development biopharmaceutical company. The Company focuses on and develops therapies for the Central Nervous System (CNS) in cases such as Parkinson's disease, neuropathic low back pain and other cognitive disorders.

Contact Information

Newron Pharmaceuticals SpA

via Ludovico Ariosto 21
Bresso (Mi), 20091
Italy
Phone: 39-02-610-3461
Fax: 39-02-610-34654

Key Executives for Newron Pharmaceuticals SpA (NWRN)

Stefan WeberCEO/CFO/Investor RelationsMarco CaremiExec VP:Business Development
Ravi AnandChief Medical OfficerRoberto GalliVP:Finance/Secretary/Treasurer
Anders HaegerstrandMember-Mgmt Board

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil